The phase 3 IMforte trial(NCT05091567) demonstrated benefit for expanding on maintenance immunotherapy in extensive-stage ...
Three inmates were killed and a corrections officer and several other inmates were injured when a fight broke out at a state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback